Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies

Jan Damoiseaux(Maastricht University), Arad Dotan(Sheba Medical Center), Marvin J. Fritzler(University of Calgary), Dimitrios P. Bogdanos(University of Thessaly), Pier Luigi Meroni(Istituti di Ricovero e Cura a Carattere Scientifico), Dirk Roggenbuck(Brandenburg University of Technology Cottbus-Senftenberg), Michel Goldman, Nils Landegren(Uppsala University), Paul Bastard(Rockefeller University), Yehuda Shoenfeld(Tel Aviv University), Karsten Conrad(TU Dresden)
Autoimmunity Reviews
December 9, 2021
Cited by 87Open Access
Full Text

Abstract

The relation between infections and autoimmune diseases has been extensively investigated. Multiple studies suggest a causal relation between these two entities with molecular mimicry, hyperstimulation and dysregulation of the immune system as plausible mechanisms. The recent pandemic with a new virus, i.e., SARS-CoV-2, has resulted in numerous studies addressing the potential of this virus to induce autoimmunity and, eventually, autoimmune disease. In addition, it has also revealed that pre-existing auto-immunity (auto-Abs neutralizing type I IFNs) could cause life-threatening disease. Therefore, the topic of the 15th Dresden Symposium on Autoantibodies was focused on autoimmunity in the SARS-CoV-2 era. This report is a collection and distillation of the topics presented at this meeting.


Related Papers

No related papers found

Powered by citation graph analysis